In the original publication of this article Fig. 2A is incorrectly published. The correct version of Fig. 2A and the following corrections are provided in this erratum.
Under the section "The rationale for the investigation of CAR IS" the line starting with "the surface of an tumour cell or infected target cell" is incorrect, it should be read as "the surface of a tumour cell or infected target cell".
Under the section of "COMPLIANCE WITH ETHICS GUIDELINES" the line starting with "This article does not contain any studies" is incorrect, it should be read as "This article does not contain any studies with human or animal subjects performed by any of the authors".
Under the section "Development of "off-the-shelf" NK cell products" the line starting with "The CAR-modified NK92 cell line may" is incorrect, it should be read as "The CAR-modified NK92 cell line may serve as a future "off-the-shelf".
Under the section "The background of IS" the line starting with "between peripheral blood NK cells in the YTS cell line and various transfectants" is incorrect, it should be read as "between peripheral blood NK cells and various transfectants".
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